香港股市 已收市

Medicover AB (publ) (0RPS.L)

LSE - LSE 延遲價格。貨幣為 SEK。
加入追蹤清單
188.00+0.08 (+0.04%)
市場開市。 截至 09:52AM BST。

Medicover AB (publ)

Riddargartan 12A
P.O. Box 5283
Stockholm 102 46
Sweden
46 8 40 01 76 00
https://www.medicover.com

版塊
行業
全職員工45,316

高階主管

名稱頭銜支付行使價出生年份
Mr. Fredrik RågmarkCEO & Director1.08M1963
Mr. Joe RyanChief Financial Officer1965
Mr. Jaroslaw UrbanczykChief Information Officer1968
Hanna BjellquistHead of Investor Relations
Ms. Jenny BrandtGeneral Legal Counsel1974
Dr. Andrew Vallance-Owen FRCS Ed, MBAChief Marketing Officer1951
Ms. Kamila SkorupinskiGroup Chief People Officer
Mr. John Paul StubbingtonChief Operating Officer of Healthcare Services1968
Mr. Staffan TernstromChief Operating Officer for Diagnostic Services1965
截止 2023年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 SEK。

描述

Medicover AB (publ) provides healthcare and diagnostic services in Poland, Sweden, and internationally. The company's Healthcare services includes service outpatient and inpatient care; dental services; other services, including non-medical related services, such as sports memberships, benefit cards, and optics, as well as wellness services; hospital care; and preventive care. Its Diagnostic services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology. It serves corporate, individuals, and public payers. Medicover AB (publ) was founded in 1995 and is headquartered in Stockholm, Sweden.

公司管治

截至 2024年5月1日 止,Medicover AB (publ) 的 ISS 管治質素評分為 6。 Pillar 分數正在審核中:1;董事會:7;股東權利:9;現金賠償:5。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。